Application 077993
- Type
- ANDA
- Sponsor
- ROXANE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | OLANZAPINE | OLANZAPINE | TABLET; ORAL | 5MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Olanzapine | OLANZAPINE | HEC Pharm USA Inc. | 4d1b83db-54db-d51f-e063-6394a90a4a69 | 2026-03-16 | Boxed warning, Warnings, Adverse reactions | Olanzapine OLANZAPINE |
| OLANZAPINE | OLANZAPINE | HEC Pharm USA Inc. | 4d34f8f3-edc8-0a68-e063-6394a90a9c1f | 2026-03-16 | Boxed warning, Warnings, Adverse reactions | OLANZAPINE OLANZAPINE |
| Olanzapine | OLANZAPINE | Dr.Reddy's Laboratories Limited | aff02cff-d079-bc82-6182-a24c4c6e09a6 | 2026-03-09 | Boxed warning, Warnings, Adverse reactions | Olanzapine OLANZAPINE |
| Olanzapine | OLANZAPINE | Dr. Reddy's Laboratories Inc. | d474d5a9-d338-511d-5823-567c0a1bbf4d | 2026-03-09 | Boxed warning, Warnings, Adverse reactions | Olanzapine OLANZAPINE |
| OLANZAPINE | OLANZAPINE | Anthea Pharma Private Limited | e6ffcc56-63f9-4b12-a07a-c6177ffef5e8 | 2026-03-06 | Boxed warning, Warnings, Adverse reactions | OLANZAPINE OLANZAPINE |
| Olanzapine | OLANZAPINE | Macleods Pharmaceuticals Limited | 8e095987-bdea-42f2-9550-c7155cf07d30 | 2026-03-05 | Boxed warning, Warnings, Adverse reactions | Olanzapine OLANZAPINE |
| Olanzapine | OLANZAPINE | Macleods Pharmaceuticals Limited | df43938a-3469-40eb-8166-f0a2fd29d6d8 | 2026-03-05 | Boxed warning, Warnings, Adverse reactions | Olanzapine OLANZAPINE |
| OLANZAPINE | OLANZAPINE | Torrent Pharmaceuticals Limited | 2cb1bebe-0ced-46d8-bf21-c28a9acc4a15 | 2026-03-02 | Boxed warning, Warnings, Adverse reactions | OLANZAPINE OLANZAPINE |
| Olanzapine | OLANZAPINE | American Regent, Inc. | e9ac2bd3-dbff-4b1a-952f-da3909c6e4ee | 2026-03-01 | Boxed warning, Warnings, Adverse reactions | Olanzapine OLANZAPINE |
| Olanzapine | OLANZAPINE | Teva Pharmaceuticals USA, Inc. | dd0b2525-4e2f-44fc-9302-0ae4ebb1e135 | 2026-02-27 | Boxed warning, Warnings, Adverse reactions | Olanzapine OLANZAPINE |
| Olanzapine | OLANZAPINE | Sandoz Inc | c44a96cc-817d-4eb5-a13a-00977f76e666 | 2026-02-26 | Boxed warning, Warnings, Adverse reactions | Olanzapine OLANZAPINE |
| Olanzapine | OLANZAPINE | American Health Packaging | c0d705bf-b719-4c7b-b83d-c17d41cbbfad | 2026-02-20 | Boxed warning, Warnings, Adverse reactions | Olanzapine OLANZAPINE |
| Olanzapine | OLANZAPINE | Sandoz Inc | 1e9666ef-4271-4834-8496-ccb3125d83db | 2026-02-19 | Boxed warning, Warnings, Adverse reactions | Olanzapine OLANZAPINE |
| OLANZAPINE | OLANZAPINE | Eugia US LLC | 9c745e2e-89d3-44d4-906e-704705c33310 | 2026-02-17 | Boxed warning, Warnings, Adverse reactions | OLANZAPINE OLANZAPINE |
| Zyprexa | OLANZAPINE | H2-Pharma LLC | b418946a-1ab4-4d89-a012-d94fc361a3c4 | 2026-02-11 | Boxed warning, Warnings, Adverse reactions | OLANZAPINE |
| Olanzapine | OLANZAPINE | Aurobindo Pharma Limited | 636665be-9d7e-443a-8134-e8cc47e6ba24 | 2026-02-10 | Boxed warning, Warnings, Adverse reactions | Olanzapine OLANZAPINE |
| Olanzapine | OLANZAPINE | Coupler LLC | 495efc49-7cdb-4b9e-e063-6394a90a547e | 2026-01-27 | Boxed warning, Warnings, Adverse reactions | Olanzapine OLANZAPINE |
| Olanzapine | OLANZAPINE | Ascend Laboratories, LLC | e8626e68-088d-47ff-bf06-489a778815aa | 2025-12-23 | Boxed warning, Warnings, Adverse reactions | Olanzapine OLANZAPINE |
| Olanzapine | OLANZAPINE | Apotex Corp. | 3347d1c8-04c9-5ce1-8cda-b38e0412b709 | 2025-11-18 | Boxed warning, Warnings, Adverse reactions | Olanzapine OLANZAPINE |
| Olanzapine | OLANZAPINE | Coupler LLC | 42d9ad47-52cc-ad11-e063-6394a90aedca | 2025-11-05 | Boxed warning, Warnings, Adverse reactions | Olanzapine OLANZAPINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.